Adalat LA 20mg tablets

Страна: Великобритания

Язык: английский

Источник: MHRA (Medicines & Healthcare Products Regulatory Agency)

Активный ингредиент:

Nifedipine

Доступна с:

Bayer Plc

код АТС:

C08CA05

ИНН (Международная Имя):

Nifedipine

дозировка:

20mg

Фармацевтическая форма:

Modified-release tablet

Администрация маршрут:

Oral

класс:

No Controlled Drug Status

Тип рецепта:

Caution - AMP level prescribing advised

Обзор продуктов:

BNF: 02060200; GTIN: 5010605005121

тонкая брошюра

V 025_0
Page 1 of 8
Due to regulatory changes, the content of the following Patient
Information Leaflet may vary from the one found in your medicine pack.
Please compare the 'Leaflet prepared/revised date' towards the end of
the leaflet to establish if there have been any changes.
If you have any doubts or queries about your medication, please
contact
your doctor or pharmacist.
_ _
PACKAGE LEAFLET: INFORMATION FOR THE USER
ADALAT
 LA 20 MG
Prolonged-release tablets
NIFEDIPINE
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even if their signs of
illness are the same as yours.
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
WHAT ADALAT LA IS AND WHAT IT IS USED FOR
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE ADALAT LA
3.
HOW TO TAKE ADALAT LA
4.
POSSIBLE SIDE EFFECTS
5.
HOW TO STORE ADALAT LA
6.
CONTENTS OF THE PACK AND OTHER INFORMATION
_ _
_ _
1.
WHAT ADALAT LA IS AND WHAT IT IS USED FOR
Adalat
LA
contains
nifedipine,
which
belongs
to
a
group
of
medicines
called
_calcium _
_antagonists. _
ADALAT LA IS USED TO TREAT HIGH BLOOD PRESSURE OR ANGINA _(chest
pain)_.
V 025_0
Page 2 of 8
For high blood pressure: Adalat LA works by relaxing and expanding the
blood vessels. This
makes the blood flow more easily and lowers blood pressure. Lower
blood pressure reduces
the strain on your heart.
For angina: Adalat LA works by relaxing and expanding the arteries
supplying the heart. This
allows more blood and oxygen to reach the heart and decreases the
strain on it. Your angina
attacks will be less severe and less frequent if there is less strain
on the heart.
_ _
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE ADALAT LA
_ _
DO

Характеристики продукта

OBJECT 1
ADALAT LA 20 MG PROLONGED-RELEASE TABLETS
Summary of Product Characteristics Updated 12-Oct-2017 | Bayer plc
1. Name of the medicinal product
Adalat LA 20 mg prolonged-release tablets
2. Qualitative and quantitative composition
Each prolonged-release tablet contains 20 mg nifedipine.
Each tablet contains a 10% overage of nifedipine to deliver the label
claim.
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Prolonged-release tablet.
Pink, round, convex prolonged-release tablet with a laser hole on one
side and marked with Adalat 20.
4. Clinical particulars
4.1 Therapeutic indications
For the treatment of mild to moderate hypertension.
For the prophylaxis of chronic stable angina pectoris either as
monotherapy or in combination with a
beta-blocker.
4.2 Posology and method of administration
_Posology_
In mild to moderate hypertension, the recommended initial dose is one
20 mg tablet once-daily. If
necessary, the dosage can be increased according to individual
requirements up to a maximum of 90 mg
once-daily.
For the prophylaxis of angina pectoris, the recommended initial dose
is one 30 mg tablet once-daily. The
dosage can be increased according to individual requirements up to a
maximum of 90 mg once-daily.
Patients in whom hypertension or anginal symptoms are controlled on
Adalat capsules or Adalat retard
may be safely switched to Adalat LA. Prophylactic anti-anginal
efficacy is maintained when patients are
switched from other calcium antagonists such as diltiazem or verapamil
to Adalat LA. Patients switched
from other calcium antagonists should initiate therapy at the
recommended initial dose of 30 mg Adalat
LA once-daily. Subsequent titration to a higher dose may be initiated
as warranted clinically.
Co-administration with CYP 3A4 inhibitors or CYP 3A4 inducers may
result in the recommendation to
adapt the nifedipine dose or not to use nifedipine at all (see section
4.5).
_Duration of treatment_
Treatment may be continued indefinitely.
_Additional information on special populatio